Hold on, science never ends, amiright?<p>I want to focus on this article:<p><a href="https://sciencebasedmedicine.org/pfizer-new-covid-19-protease-inhibitor-drug-is-not-just-repackaged-ivermectin/" rel="nofollow">https://sciencebasedmedicine.org/pfizer-new-covid-19-proteas...</a><p>Where they conclude:<p>"Spoiler alert: Ivermectin does inhibit the same protease that PF-07321332 does, but, as is the case for viral replication, it requires a concentration that is not achievable by oral dosing."<p>So Ivermection COULD work. That is not me saying that, that is an scientific article debunking Ivermectin. (As an aside, the politics of this, they will not even say that yes, ivermection COULD work but the dose needed would be too high).<p>But the protease all these drugs try to inhibit is TMPRSS2. Now TMPRSS2 is made by a gene, and genetic changes affect the amount of this enzyme, leading to higher or lower function.<p><a href="https://academic.oup.com/jid/article/212/8/1214/2193475" rel="nofollow">https://academic.oup.com/jid/article/212/8/1214/2193475</a><p>These gene changes could make us more or less vulnerable to COVID in some populations:<p><a href="https://www.biorxiv.org/content/10.1101/2021.10.04.463014v1" rel="nofollow">https://www.biorxiv.org/content/10.1101/2021.10.04.463014v1</a><p>So, unless you filter out genetic diversity (which they never do) you will never find out the population Ivermectin MIGHT help. Maybe it would help someone like me who carries that polymorphism. Maybe that is why it seems to work well in other countries?<p>And what about checking if these patients were zinc deficient or not? Because ADAM17 uses zinc, and ADAM17 snips ACE2 off of the cell making Soluble ACE2. SARS2 will attach to this soluble ACE2 not allowing TMPRSS2 to let SARS2 into the cell.<p><a href="https://www.frontiersin.org/files/Articles/576745/fimmu-11-576745-HTML/image_m/fimmu-11-576745-g001.jpg" rel="nofollow">https://www.frontiersin.org/files/Articles/576745/fimmu-11-5...</a><p><a href="https://www.ahajournals.org/cms/asset/36a2c66b-1ca8-43e9-944e-217a170f33fd/hypertensionaha.120.15082.fig01.gif" rel="nofollow">https://www.ahajournals.org/cms/asset/36a2c66b-1ca8-43e9-944...</a><p>So maybe, if someone has enough zinc then ivermectin, or any protease inhibitor, will be more effective at lower doses?<p>And you know that people with river blindness, the thing Ivermectin treats, have lower levels of zicn and supplementation is urged in these patients:<p><a href="http://www.sciencepub.net/nature/0504/03_0312_nmorsi_serum_ns0504.pdf" rel="nofollow">http://www.sciencepub.net/nature/0504/03_0312_nmorsi_serum_n...</a> (PDF)<p>"The depleted mean serum trace elements in the infected volunteers than their control subjects implicated the deficiency of copper, selenuim and zinc in the pathogenesis of onchocerciasis and the need to incorporated dietary trace element supplements in management of
onchocerciasis."<p>So all of those studies, IMHO, need to be thrown out.<p>This is science, no blogs here, and I have the vaccine so I am not anti-vax. So please, don't come at me from that angle. This is a reasonable hypothesis.<p>I carry the TMPRSS2 polymorphism they mention in the article above. Yes, my experience is anecdotal, but I was discovered to have a zinc deficiency well before COVID (they had a medical reason for testing it) and supplementing with zinc ended the colds and flus I would get three times a year. It has been 10 years and I have not had only minor symptoms a few times.